Six Aims of High Quality Healthcare (Infographic)

Six Aims of High Quality Healthcare (Infographic)

In 1998, the Quality Chasm series was launched by the Institute of Medicine which included an informative report about delivering high quality healthcare. The report was entitled  “Crossing the Quality Chasm: A New Health System for the 21st Century”.The strategies proposed in this report were to be used as an organizational model for a patient centered healthcare system, and to provide informative guidelines on how a healthcare delivery system can be redesigned to innovate and improve care. 

This informative report uses six primary aims to achieve and implement  high quality healthcare systems. Mobile Health solutions, such as our mHealth solution,  can meet all of those six aims.  See how below: 

An infographic of how the monsenso solution does meet the six aims of high quality digital healthcare

Using mobile technology to reduce hospital re-admissions

Using mobile technology to reduce hospital re-admissions

The U.S Healthcare Information and Management Systems Society (HiMSS) released a report titled “Leveraging mobile technology to reduce hospital readmissions.”

According to the Centres for Medicare and Medicaid Services (CMS), Medicare has been overwhelmed with excessive hospital re-admissions – with total costs up to $17.5 billion a year. [1]

From 2007 to 2010, the national re-admissions rate remained at 19.2%, with an average Medicare cost for a hospital readmission stay at $9,600.

Therefore, the Hospital Re-admissions Reduction Program (HRRP), under the Affordable Care Act (ACA), aims to reduce re-admissions for all acute-care hospitals receiving payment under the Medicare Inpatient Prospective Payment System. [1]

In 2012, more than 2,000 hospitals were penalized for having excessive re-admission rates. The Medicare Payment Advisory Committee (MedPAC) estimates that these hospitals paid an average penalty of $125,000. [1]


Mobile technology ripe for greater adoption

Hospitals and health care systems are looking into developing new strategies, redesigning discharge procedures, and hiring more staff to follow up with patients at home.

They also need to rely on health information technology to scale their programs since they are also required to meet meaningful use criteria.

Hospitals and health systems are being urged to include mobile technology such as remote monitoring devices to connect patients and clinicians and impact care outside of their organizations.

According to the Pew Mobile technology fact sheet, as of October 2014, 64% of American adults have a smartphone. [2]

According to the 2015 HIMSS Mobile Technology Survey, 90% of respondents uses at least one type of mobile device to engage patients. [3]

Mobile health technology has created a demand for the concept of care from any location, which includes being able to communicate, share patient information, and receive services remotely.

The acceptance of mobile technology in the care setting continues to grow. 52% of survey respondents believe that the use of mobile technology will “substantially impact the delivery of healthcare in the future.” An additional 16% noted that the use of mobile technology will “dramatically change the way healthcare is delivered in the future.” [1]

Respondents also ranked that medication reminders, remote patient monitoring and preventative support care are benefits that mobile technology can deliver on patient care.


Overcoming the barriers

While remote monitoring technology (RMT) and mobile technology improve the quality of care and outcomes overall, barriers still exist.

In the case of mental health, mobile technology solutions like the one offered by Monsenso can help reduce the number of hospital re-admissions as well as the health care spending.

For example, a patient is brought into the emergency room as a consequence of displaying severe symptoms of mental illness.

After a couple of weeks of hospitalisation, the patient is released into the care of a close relative. Even though things seem to be going well, the patient is readmitted to the hospital again after six months.

This scenario can be quite common for people suffering from severe mental illness. Patients receive the treatment they need while being hospitalised, however once they are released into the care of their relatives, they receive no support, which gradually deteriorates their mental health.

It is very seldom that patients suffering from mental illness are called in for follow-up appointments, and as a consequence patients remain “stable” for a short period and then hospitalised after relapses.

Monsenso mobile health solution

The Monsenso mHealth solution can help reduce the number of hospital re-admissions in psychiatric treatment. Once a patient is released from the hospital, clinicians can establish a remote care plan that includes monitoring and self-treatment.

Every day, patients will complete a self-assessment in their smartphone. The information on the self-assessment is synchronized in real-time with the clinical web portal.

With the information obtained from the self-assessments, the system can identify the triggers and early warning signs of all active patients. A clinician can access the system every morning and be informed on which patients may need urgent care.

After accessing the patient’s records and reviewing the patient’s behavioural patterns, the clinician can make an informed decision. He can determine if the patient needs to be called in for an emergency appointment or just monitored more closely.

The clinician can also send an encrypted message to the patient asking if everything is fine and encouraging the patient to reach out if he feels ill.

In addition, the Monsenso mHealth solution provides patients with personalised action plans that suggest certain activities in case the patient displays certain symptoms.

Sources:

[1] Leveraging mobile technology to reduce hospital readmissions. Healthcare Information and Management Systems Society (HiMSS). 2013 http://www.mhealthnews.com/resource/leveraging-mobile-technology-reduce-hospital-readmissions

[2] Mobile technology fact sheet. Pew Research Center. 2014 http://www.pewinternet.org/fact-sheets/mobile-technology-fact-sheet/

[3] Mobile technology survey. Healthcare Information and Management Systems Society (HiMSS). 2015 http://www.himss.org/ResourceLibrary/genResourceDetailPDF.aspx?ItemNumber=42595

Monsenso’s mobile health solution will be used in H2020 Funded ECoWeB Project

Monsenso’s mobile health solution will be used in H2020 Funded ECoWeB Project

Monsenso’s mHealth solution will feature additions for the ECoWeB project, which focuses on training and enhancing emotional competency skills for youth populations    

Copenhagen, Denmark – 24 April 2018 Monsenso is happy to announce the involvement of our mHealth solution in the Horizon 2020 Funded ECoWeB Project.

The ECoWeB project aims to provide a comprehensive and personalized mobile app that will train young individuals in enhancing their emotional control skills and minimizing their emotional deficits. Monsenso’s mHealth solution is the foundation for the project. The app will work closely with the 3 major components of Emotional Control: Production, Regulation & Knowledge. It is hypothesized that interventions based on such comprehensive assessments will efficiently increase resilience toward adversity, promote mental wellbeing and act as a primary prevention for mental disorders.

“The Monsenso mHealth solution offers a perfect foundation for the ECoWeB project. I am confident that the routine monitoring, and high customizability of the solution can be modified to help young individuals enhance important emotional competency skills.” says Ed Watkins, Professor of Experimental and Applied Clinical Psychology at the College of Life & Environmental Sciences for Exeter University.

This project adopts a new approach to the fundamental understanding of emotion, by combining a highly personalized approach to understanding the individual and leading digital technology. This innovative approach has the potential to deliver a breakthrough in the effective prevention of mental disorders.

The ECoWeB project will integrate the following three multidisciplinary approaches:

  1. The use of the theoretical model of normal emotional functioning (The Emotional Competence Process) to guide the identification and targeting of emotional competence mechanisms implicated in both the mental wellbeing and psychopathology for young people.
  2. The systematic assessment of personal Emotional Competence profiles to select targeted interventions to promote wellbeing
  3. Mobile application delivery intended for scalability, accessibility and adaptability in younger populations.

“This project is exciting because it diversifies the usage of our solution. In addition to providing a supplement for treatment in clinical practice, our solution will now be able to also be used independently to provide personalized prevention.” says Thomas Lethenborg, CEO at Monsenso.

The project is led by The University of Exeter. The consortium consists of the following members:

The project was developed in response to the need for more robust evidence on resilience factors and effective interventions for young populations, in addition to the need for scalable approaches to mental health interventions that are accessible at a population level.

The project is presently ongoing.

Click here to read the press release in Danish. 

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No.754657. 

Monsenso provides medication adherence and behavioural monitoring components in H2020 Funded R-LiNK Study

Monsenso provides medication adherence and behavioural monitoring components in H2020 Funded R-LiNK Study

Monsenso’s mHealth solution participates in the R-LiNK Study, a major new study for optimising treatment response to lithium

Copenhagen, Denmark – 16 April 2018  Monsenso is proud to announce our participation in R-LiNK – the major new study for developing a more complete understanding of the reactions and effects of taking lithium. As a part of this study, our solution will be implemented for 300 participants across 15 centres all over Europe.

Lithium is the leading treatment for patients with bipolar disorder. There is a large variability across patient responses when taking lithium. This variability makes it difficult for clinicians to predict how patients will respond to being prescribed lithium.

“Lithium is the oldest drug treatment used regularly in psychiatry and one that has shown evidence of many benefits over the decades it has been used. However, only about one third of patients are “excellent” responders with a future two thirds showing partial or no response. This large EU funded study takes place across Europe and aims to find out which “biomarkers” can be used to predict which patients will respond and for those whom lithium will not help,” said Professor Allan Young, Director of the Centre for Affective Disorders at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London.

R-Link is a multimodal approach to studying lithium initiation, and identifying important biomarkers from receiving lithium treatment. The comprehensive study aims to identify factors related to better responses, safety, and tolerability of lithium treatment. The results of the study can help provide patients and clinicians alike with more accurate information to make informed decisions regarding the prescription of lithium, therefore improving the long term management and prognosis for bipolar patients.

“Mobile health technology can provide new insight into the treatment of mental health and disorders, and mobile phone usage can also provide important new biomarkers for affective disorders.” said Professor Lars Kessing, of the Psychiatric Center Copenhagen and the University of Copenhagen, Faculty of Health Sciences.

The Monsenso mHealth solution will be involved in the phase of the study that will conduct a qualitative and quantitative study on the acceptability and efficacy of connected ecological devices to monitor mood, lithium levels, symptoms, daily behaviour, and enhance patient adherence. Therefore, the solution will include data collection of lithium adherence and outcome/behaviour reporting (via sensor data and daily self-assessment).

“Ensuring adherence to medical treatment on an individual level is key to a successful mental health treatment. Our mHealth solution will contribute to this study by promoting medical adherence, through providing easy, personalised self-monitoring and medication tracking, as well as medication reminders.” said Thomas Lethenborg, CEO of Monsenso.

This study also has the potential to enable the personalisation of lithium based treatment. Findings from this study can also contribute to the overall prevention and reduction of unnecessary side effects from lithium treatment as well as overall ineffective treatments.
Monsenso is now involved in more than ten pan European and domestic research projects in the mental health & affective disorders field.

The study is presently ongoing.

Click here to read the press release in Danish. 

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No.754907. 

Monsenso leads mental health component of H2020 funded WellCo Virtual Coach for Behavioural Changes

Monsenso leads mental health component of H2020 funded WellCo Virtual Coach for Behavioural Changes

Monsenso’s mHealth solution will lead the mental health component of a new ICT solution designed to help users maintain or improve their physical, cognitive, mental, and social well-being. 

Copenhagen, Denmark – 6 February 2018 Monsenso is proud to be a consortium partner in the international team consisting of SME companies, universities, and research centres for the Horizon 2020 funded WellCo project.

Led by Spanish ICT company Hi-Iberia, the WellCo project will deliver a radically new ICT solution focused on encouraging users to adopt and maintain healthier behavioural choices to help improve their long-term physical, cognitive, mental, and social well-being. The study will mostly be working with older participants.

“WellCo’s aim is to change behaviours and promote a healthy living that will be translated in better quality of life for seniors. One of the main factors is to ensure the acceptance and maintenance of the healthy behaviors promoted by WellCo. The WellCo application will try to make use of the technology as a tool to personalize and tailor these recommendations to the specific needs and preferences of each user.” says Inmaculada Luengo of Hi-Iberia.

The solution will consist of many components, including a comprehensive assessment, personalised advice, and supervised guidance & follow-up for users. WellCo interventions will be guided by an affective aware virtual coach that, through using state of the art technologies in AI (artificial intelligence), will interactively guide and empower users towards important behavioural changes.

Monsenso’s mHealth solution will help contribute experience and knowledge to the project, by providing comprehensive routine monitoring and detailed data collection for assessing the participant’s behaviour.

“We play a leading role in the development of the user assessment and in the design of the virtual coach, and we will also be involved in the prototyping and dissemination components,” says Thomas Lethenborg, CEO of Monsenso. “We are excited to see how we can build on our remote monitoring and sensor data functionality, in order to contribute to collecting longitudinal data to help improve the mental health of participants.”

The virtual coach will be tested in trial in Trento in Italy, Castilla y León in Spain, Copenhagen and the Southern Denmark area in Denmark. There will be a minimum of 150 end-users included in the study. The study will be continuously supported by a multidisciplinary team of experts and users’ close caregivers to ensure the effectiveness and accuracy of the guided wellness interventions.

Other Danish Involvement in the Project 

In Denmark, the University of Copenhagen and The University of Southern Denmark will be working alongside Monsenso in the study.

The University of Copenhagen will contribute to the study with the Quality of Life Lab, which explores the development and evaluation of personal behavioural health metrics by examining how sensor data can be used as a minimally obtrusive method to accurately and longitudinally measure an individual’s behaviour. The lab will also examine how an individual’s quality of life naturally unfolds over time; within this context, the lab will also examine which behavioural change methods can be used to improve the individual’s overall quality of life.

“It is very exciting to be involved in this study and to see how sensor data and remote monitoring can work together to offer a better, more informed, detailed picture of individual’s behaviours for the assessment and improvement of their quality of life and overall well-being.” says Katarzyna Wac, Quality of Life Lab leader and Associate Professor at the University of Copenhagen.

The solution will be implemented, demonstrated, and piloted at The University of Southern Denmark.

“We will be very interested to see how this project effects our elderly patients and their wellbeing, and how much more data and information can be extracted with the use of remote monitoring and sensor data tools,” says Torben Uhrenholt of The University of Southern Denmark.

The Monsenso solution is currently being used in Region South Denmark Clinics.

Consortium Members 

The consortium consists of:

  • 3 SME companies: H-Iberia, a Spanish ICT solution supplying company, Connected Care from The Netherlands and Monsenso
  • Two universities: The University of Copenhagen and The University of Southern Denmark
  • One research center: Jozef Stefan Institute (Slovenia) and two end-user organisations Fondazione Bruno Kessler (Italy) and Gerencia Servicios Sociales Castilla y León (Spain)

The project has launched on December 4th in Madrid and will continue until the end of 2020.

Click here to read the press release in Danish.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No.769765.

About Monsenso: Monsenso is an innovative technology company based in Denmark that offers a comprehensive mHealth solution to optimise the treatment of mental disorders. Our mission is to assist healthcare providers, researchers and individuals in coping with and overcoming the burden of mental illness. Our solution provides a detailed overview of the patient’s mental health through the automatic collection of behavioural data and routine self-monitoring. Our team is committed to developing complete and effective solutions that fit seamlessly within the lives of individuals, in order to increase the quality and efficacy of their treatment.

For additional information, please contact:
Thomas Lethenborg
CEO
Monsenso
+45 30 25 15 26
http://info@monsenso.com

Torben Uhrenholt
IT Project Leader
tuhrenholt@health.sdu.dk

Katarzyna Wac
Quality of Life Lab Leader and Associate Professor at the University of Copenhagen
The University of Copenhagen
wac@di.ku.dk